Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

330 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Completed

Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib

NCT03710824

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University General Hospital of Evros Alexandroupoli, Greece
  • Gen. Hosp. of Chest Diseases "Sotiria", Univ. Resp. Med. Athens, Greece
  • University General Hospital Attikon Athens, Greece
  • General Hospital of Kerkyra Corfu, Greece
View Trial Details
Completed

Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001

NCT05657184

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis

NCT04396756

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Pulmonary Associates, PA Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center, Interstitial Lung Disease Program, Pulmonary and Critical Care Medicine Los Angeles, California, United States
  • Yale University Scool of Medicine/ Yale New Haven Hospital New Haven, Connecticut, United States
  • The Emory Clinic Atlanta, Georgia, United States
View all 20 locations
View Trial Details
Completed

Safety and Effectiveness of Nintedanib in Korean Patients

NCT04525547

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Dong-A University Hospital Busan, South Korea
  • Chungbuk national University Hospital Chungcheongbuk-do, South Korea
  • SoonChunHyang University Cheonan Hospital Chungcheongnam-do, South Korea
  • Keimyung University Dongsan Hospital Daegu, South Korea
View all 22 locations
View Trial Details

Related conditions